BridgeBio Pharma Inc (NASDAQ:BBIO)
| 39.63 Delayed Data As of 3:59pm ET |  +0.06 / +0.15%Today’s Change | 14.23 Today|||52-Week Range 48.36 | +13.07% Year-to-Date |
Latest BBIO News | Press Releases
No recent news for BridgeBio Pharma Inc.
Today’s Trading
| Previous close | 39.57 |
| Today’s open | 40.70 |
| Day’s range | 38.31 - 39.70 |
| Volume | 28,913 |
| Average volume (3 months) | 685,278 |
| Market cap | $4.8B |
Data as of 3:59pm ET, 10/26/2020
Growth & Valuation
| Earnings growth (last year) | -111.73% |
| Earnings growth (this year) | -38.49% |
| Earnings growth (next 5 years) | -67.71% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 90.82 |
| Price/Book | 11.98 |
Competitors
Data as of 4:00pm ET, 10/26/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $40.6M |
| Annual profit (last year) | -$260.6M |
| Net profit margin | -642.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
